Credit Suisse’s Caribou Biosciences CRBU Stock Holding History

Credit Suisse’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$57.6K	Hold	11,210	–	–	﹤0.01%	2941
2023 Q4	$64.2K	Sell	11,210 -3,978	-26%	-$19.7K	﹤0.01%	3040
2023 Q3	$72.6K	Buy	+15,188	New	+$94.2K	﹤0.01%	3110
2023 Q2	–	Sell	-58,862	Closed	-$313K	–	3185
2023 Q1	$313K	Buy	58,862 +6,846	+13%	+$42.6K	﹤0.01%	2982
2022 Q4	$327K	Buy	52,016 +17,020	+49%	+$151K	﹤0.01%	2994
2022 Q3	$368K	Buy	34,996 +2,360	+7%	+$22K	﹤0.01%	2978
2022 Q2	$177K	Buy	32,636 +13,921	+74%	+$106K	﹤0.01%	3371
2022 Q1	$172K	Buy	18,715 +2,252	+14%	+$23.7K	﹤0.01%	3405
2021 Q4	$247K	Buy	+16,463	New	+$320K	﹤0.01%	4199

Other funds holding CRBU

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

EWM

Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse's CRBU Position: Q1 2024 in Review

Credit Suisse held its Caribou Biosciences (CRBU) position steady in Q1 2024 at 11,210 shares worth $57.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2941.

Credit Suisse first reported a position in CRBU in Q4 2021 and has held it in 9 quarters since. The position peaked at $368K in Q3 2022. 151 funds tracked by Wall St. Rank hold CRBU as of Q1 2024.

Credit Suisse held 11,210 shares of Caribou Biosciences worth $57.6K as of Q1 2024.
Credit Suisse left its Caribou Biosciences share count unchanged in Q1 2024.
Caribou Biosciences made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2941 holding.
Credit Suisse first reported a position in Caribou Biosciences in Q4 2021 and has held it in 9 quarters since.
Credit Suisse's Caribou Biosciences position peaked at $368K in Q3 2022.
151 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.